921 related articles for article (PubMed ID: 17591692)
1. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.
Peterson TJ; Karmakar S; Pace MC; Gao T; Smith CL
Mol Cell Biol; 2007 Sep; 27(17):5933-48. PubMed ID: 17591692
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT.
Keeton EK; Brown M
Mol Endocrinol; 2005 Jun; 19(6):1543-54. PubMed ID: 15802375
[TBL] [Abstract][Full Text] [Related]
3. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.
Yoon HG; Wong J
Mol Endocrinol; 2006 May; 20(5):1048-60. PubMed ID: 16373395
[TBL] [Abstract][Full Text] [Related]
4. Cooperative activation of cyclin D1 and progesterone receptor gene expression by the SRC-3 coactivator and SMRT corepressor.
Karmakar S; Gao T; Pace MC; Oesterreich S; Smith CL
Mol Endocrinol; 2010 Jun; 24(6):1187-202. PubMed ID: 20392877
[TBL] [Abstract][Full Text] [Related]
5. Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT).
Shibata H; Nawaz Z; Tsai SY; O'Malley BW; Tsai MJ
Mol Endocrinol; 1997 Jun; 11(6):714-24. PubMed ID: 9171235
[TBL] [Abstract][Full Text] [Related]
6. Characterization of receptor interaction and transcriptional repression by the corepressor SMRT.
Li H; Leo C; Schroen DJ; Chen JD
Mol Endocrinol; 1997 Dec; 11(13):2025-37. PubMed ID: 9415406
[TBL] [Abstract][Full Text] [Related]
7. G protein pathway suppressor 2 (GPS2) is a transcriptional corepressor important for estrogen receptor alpha-mediated transcriptional regulation.
Cheng X; Kao HY
J Biol Chem; 2009 Dec; 284(52):36395-36404. PubMed ID: 19858209
[TBL] [Abstract][Full Text] [Related]
8. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.
Klinge CM; Jernigan SC; Mattingly KA; Risinger KE; Zhang J
J Mol Endocrinol; 2004 Oct; 33(2):387-410. PubMed ID: 15525597
[TBL] [Abstract][Full Text] [Related]
9. Scaffold attachment factor SAFB1 suppresses estrogen receptor alpha-mediated transcription in part via interaction with nuclear receptor corepressor.
Jiang S; Meyer R; Kang K; Osborne CK; Wong J; Oesterreich S
Mol Endocrinol; 2006 Feb; 20(2):311-20. PubMed ID: 16195251
[TBL] [Abstract][Full Text] [Related]
10. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT.
Jackson TA; Richer JK; Bain DL; Takimoto GS; Tung L; Horwitz KB
Mol Endocrinol; 1997 Jun; 11(6):693-705. PubMed ID: 9171233
[TBL] [Abstract][Full Text] [Related]
11. Corepressor subnuclear organization is regulated by estrogen receptor via a mechanism that requires the DNA-binding domain.
Voss TC; Demarco IA; Booker CF; Day RN
Mol Cell Endocrinol; 2005 Feb; 231(1-2):33-47. PubMed ID: 15713534
[TBL] [Abstract][Full Text] [Related]
12. Response of SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) and N-CoR (nuclear receptor corepressor) corepressors to mitogen-activated protein kinase kinase kinase cascades is determined by alternative mRNA splicing.
Jonas BA; Varlakhanova N; Hayakawa F; Goodson M; Privalsky ML
Mol Endocrinol; 2007 Aug; 21(8):1924-39. PubMed ID: 17519355
[TBL] [Abstract][Full Text] [Related]
13. Dominant-negative nuclear receptor corepressor relieves transcriptional inhibition of retinoic acid receptor but does not alter the agonist/antagonist activities of the tamoxifen-bound estrogen receptor.
Morrison AJ; Herrera RE; Heinsohn EC; Schiff R; Osborne CK
Mol Endocrinol; 2003 Aug; 17(8):1543-54. PubMed ID: 12730327
[TBL] [Abstract][Full Text] [Related]
14. Nuclear corepressor and silencing mediator of retinoic and thyroid hormone receptors corepressor expression is incompatible with T(3)-dependent TRH regulation.
Becker N; Seugnet I; Guissouma H; Dupre SM; Demeneix BA
Endocrinology; 2001 Dec; 142(12):5321-31. PubMed ID: 11713232
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of MAP kinase promotes the recruitment of corepressor SMRT by tamoxifen-bound estrogen receptor alpha and potentiates tamoxifen action in MCF-7 cells.
Hong W; Chen L; Li J; Yao Z
Biochem Biophys Res Commun; 2010 May; 396(2):299-303. PubMed ID: 20406620
[TBL] [Abstract][Full Text] [Related]
16. The functional relationship between co-repressor N-CoR and SMRT in mediating transcriptional repression by thyroid hormone receptor alpha.
Choi KC; Oh SY; Kang HB; Lee YH; Haam S; Kim HI; Kim K; Ahn YH; Kim KS; Yoon HG
Biochem J; 2008 Apr; 411(1):19-26. PubMed ID: 18052923
[TBL] [Abstract][Full Text] [Related]
17. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.
Fleming FJ; Hill AD; McDermott EW; O'Higgins NJ; Young LS
J Clin Endocrinol Metab; 2004 Jan; 89(1):375-83. PubMed ID: 14715875
[TBL] [Abstract][Full Text] [Related]
18. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen.
Smith CL; Nawaz Z; O'Malley BW
Mol Endocrinol; 1997 Jun; 11(6):657-66. PubMed ID: 9171229
[TBL] [Abstract][Full Text] [Related]
19. Signaling by tyrosine kinases negatively regulates the interaction between transcription factors and SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) corepressor.
Hong SH; Wong CW; Privalsky ML
Mol Endocrinol; 1998 Aug; 12(8):1161-71. PubMed ID: 9717842
[TBL] [Abstract][Full Text] [Related]
20. Progesterone receptor B recruits a repressor complex to a half-PRE site of the estrogen receptor alpha gene promoter.
De Amicis F; Zupo S; Panno ML; Malivindi R; Giordano F; Barone I; Mauro L; Fuqua SA; Andò S
Mol Endocrinol; 2009 Apr; 23(4):454-65. PubMed ID: 19147702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]